Soon, nasal spray vaccines to curb fluPublished On: Tue, Apr 12th, 2011 | Microbiology | By BioNews
Scientists from Albany Medical College, New York, are one step closer in developing a nasal spray that is more effective against flu, pneumonia and even bioterrorism agents, such as Yersinia pestis that causes the plague, than an injection.
They showed how including a natural immune chemical with standard vaccines could boost their protective effect when delivered through the nose.
The respiratory tract is a major entry site for various viral and bacterial pathogens.
However, there are few approved vaccines that can provide optimal protection against them due to the low immune response at muscosal surfaces such as the nasal passage.
Combining standard vaccines for respiratory pathogens with the immune chemical, interleukin-12 (IL-12) and delivering them intranasally to mice has been shown to induce high levels of protection. Vaccines against various respiratory pathogens were tested, including influenza virus, pneumococcal bacteria and Yersinia pestis – a Category A Biothreat. IL-12 is a natural immune chemical, known as a cytokine. It is a powerful stimulator of the immune response through its interactions with other immune chemicals and the white blood cells that produce them.
“Infectious agents still account for around 25 pc of deaths worldwide and the major killers are acute respiratory infections. However, it is difficult to induce immunity at the site of entry and so standard vaccines are only partially protective,” said Prof Dennis Metzger.
“Intranasal vaccination gets around this problem by inducing immunity in the pulmonary passage. This prevents initial infection as well as systemic complications”. Up until now, nasal vaccination has only resulted in sufficient immune responses for very specific types of vaccine. “We now have evidence that this method could work for a wide range of vaccines when IL-12 is included in formulation,” he said.
Nasal vaccines could have a number of other advantages over vaccines that must be injected.
“Vaccination via a nasal spray is a non-invasive procedure that is easier than administering vaccines by injection. In addition our results have shown that antibodies induced by intranasal vaccination are effective not only in preventing infection but can also protect the pulmonary tract in a therapeutic manner after pathogen exposure,” explained Metzger.
“In the case of a bioterrorism threat or an influenza pandemic, this is significant,’ added Metzger.
The study was presented at the Society for General Microbiology”s Spring Conference in Harrogate.